Image may differ
AESKULISA®
Reference:
6062
Designation:
Parvovirus B19 IgG
Intended use:

The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgG
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Calibration:
WHO 01/602
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Virus-like particles (VLPs) derived from recombinant VP2
produced in insect cells infected with baculovirus
produced in baculovirus-infected insect cells
AESKULISA®

6062

Parvovirus B19 IgG

Image may differ
Intended use:

The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgG
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Calibration:
WHO 01/602
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Virus-like particles (VLPs) derived from recombinant VP2
produced in insect cells infected with baculovirus
produced in baculovirus-infected insect cells
Downloads
All related documents and information clearly summarized

Instructions for Use

Safety Data Sheet